Financhill
Sell
34

RPRX Quote, Financials, Valuation and Earnings

Last price:
$35.60
Seasonality move :
-3.28%
Day range:
$35.31 - $35.65
52-week range:
$24.05 - $36.89
Dividend yield:
2.42%
P/E ratio:
15.19x
P/S ratio:
9.26x
P/B ratio:
2.24x
Volume:
2M
Avg. volume:
4M
1-year change:
25.63%
Market cap:
$15B
Revenue:
$2.3B
EPS (TTM):
$2.34

Earnings Data

Next earnings date for RPRX
Aug 06
2025
Most recent earnings per share
$0.55
Missed by $0.40
(May 8/2025)
Consensus Estimate
$0.95
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RPRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $766.8M -- -- $1.04 --
08/06/2025 Q2 $722.8M -- -- $1.04 --
05/08/2025 Q1 $750.5M $568.2M $0.55 $0.95 -$0.40
02/11/2025 Q4 $728M $593.6M $0.35 $1.05 -$0.70
11/06/2024 Q3 $730.2M $564.7M $1.21 $0.93 $0.28
08/08/2024 Q2 $639.7M $537.3M $0.23 $0.97 -$0.74
05/09/2024 Q1 $700.8M $568M $0.01 $0.98 -$0.97
02/15/2024 Q4 $674.5M $596.1M $1.10 $1.00 $0.10
11/08/2023 Q3 $618.5M $536.3M $0.16 $0.77 -$0.61
08/08/2023 Q2 $536.6M $538.2M $0.50 $0.81 -$0.31
05/09/2023 Q1 $629.7M $684M $0.76 $1.27 -$0.51
02/15/2023 Q4 -- $565.7M -$1.47 -- --
11/08/2022 Q3 -- $573.5M $0.32 -- --
08/04/2022 Q2 -- $536M $0.70 -- --
05/05/2022 Q1 -- $562M $0.12 -- --
02/15/2022 Q4 -- $575.7M -$0.66 -- --
11/10/2021 Q3 -- $585.8M $0.24 -- --
08/11/2021 Q2 -- $555M $1.08 -- --
05/11/2021 Q1 -- $573M $0.18 -- --
02/17/2021 Q4 -- $572.1M $0.44 -- --
11/11/2020 Q3 -- $538.4M $0.79 -- --
08/12/2020 Q2 -- $510.9M $0.09 -- --
03/31/2020 Q1 -- $500.9M $0.20 -- --
12/31/2019 Q4 -- $457.5M $4.01 -- --
09/30/2019 Q3 -- $464.3M $1.15 -- --
06/30/2019 Q2 -- $457.6M $0.43 -- --
03/31/2019 Q1 -- $434.9M $1.04 -- --
03/20/2017 Q4 -- -- -- -- --
11/14/2016 Q3 -- -- -- -- --
08/08/2016 Q2 -- -- -- -- --
05/05/2016 Q1 -- -- -- -- --
03/21/2016 Q4 -- -- -- -- --
11/09/2015 Q3 -- -- -- -- --

Royalty Pharma PLC Earnings Questions

  • How Much did Royalty Pharma PLC Generate in Revenue Last Quarter?

    Royalty Pharma PLC reported $568.2M worth of top line sales in its most recent quarter.

  • Did Royalty Pharma PLC Beat Earnings Last Quarter?

    Royalty Pharma PLC announced earnings per share of $0.55 which represents a miss of analyst forecast a $0.95 per share.

  • Is Royalty Pharma PLC Profitable?

    Royalty Pharma PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Royalty Pharma PLC EPS Next Year?

    Royalty Pharma PLC's earnings are forecast to grow from $1.91 per share to $4.05 per share next year representing an increase of 130.28%.

  • When is Royalty Pharma PLC's Earnings Date?

    Royalty Pharma PLC's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock